BlackRock Fund Advisors’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $22.3M | Buy |
5,411,414
+626,133
| +13% | +$2.59M | ﹤0.01% | 2118 |
|
|
2016
Q3 | $38.8M | Buy |
4,785,281
+254,100
| +6% | +$2.06M | 0.01% | 1746 |
|
|
2016
Q2 | $35.3M | Sell |
4,531,181
-42,132
| -0.9% | -$329K | 0.01% | 1716 |
|
|
2016
Q1 | $35.3M | Buy |
4,573,313
+102,179
| +2% | +$789K | 0.01% | 1659 |
|
|
2015
Q4 | $48.2M | Sell |
4,471,134
-252,325
| -5% | -$2.72M | 0.01% | 1492 |
|
|
2015
Q3 | $32.6M | Buy |
4,723,459
+390,846
| +9% | +$2.7M | 0.01% | 1699 |
|
|
2015
Q2 | $38.4M | Sell |
4,332,613
-205,121
| -5% | -$1.82M | 0.01% | 1699 |
|
|
2015
Q1 | $44.7M | Buy |
4,537,734
+686,480
| +18% | +$6.77M | 0.01% | 1571 |
|
|
2014
Q4 | $47.2M | Buy |
3,851,254
+366,133
| +11% | +$4.49M | 0.01% | 1506 |
|
|
2014
Q3 | $34.8M | Sell |
3,485,121
-66,791
| -2% | -$667K | 0.01% | 1594 |
|
|
2014
Q2 | $26.9M | Sell |
3,551,912
-68,187
| -2% | -$516K | 0.01% | 1832 |
|
|
2014
Q1 | $11.9M | Buy |
3,620,099
+145,717
| +4% | +$479K | ﹤0.01% | 2297 |
|
|
2013
Q4 | $11.5M | Sell |
3,474,382
-71,323
| -2% | -$237K | ﹤0.01% | 2307 |
|
|
2013
Q3 | $10.7M | Buy |
3,545,705
+467,270
| +15% | +$1.41M | ﹤0.01% | 2319 |
|
|
2013
Q2 | $25.2M | Buy |
+3,078,435
| New | +$25.2M | 0.01% | 1681 |
|